Companies / Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc.

NasdaqCIK 1553643CORAL GABLES, FL

Financials · FY2013

Revenue$13.1K
Net income$-57.39M
Total debt—
Cash$11.33M
Diluted EPS$-1.45
Shares outstanding106.7M

Ownership

106.7M shares outstanding · as of Aug 4, 2026
68.1%Institutions
Ownership
Institutions68.10%72,637,384
Public float31.90%34,032,462

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 0

View all →
Insider% of sharesShares
No insiders recorded yet.

Institutional holders 85

View all →
HolderValue% of shares
Janus Henderson Group PLC$76.89M10.37%
BlackRock, Inc.$51.39M6.96%
Adage Capital Partners Gp, L.L.C.$33.15M4.47%
Orbimed Advisors LLC$32.82M4.42%
Squadron Master Fund LP$32.36M6.28%
Marshall Wace, LLP$31.19M4.20%
Millennium Management LLC$27.19M3.66%
RA Capital Management, L.P.$20.51M2.76%
Spruce Street Capital LP$19.74M3.83%
State Street Corporation$17.42M2.36%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
No activity matches these filters.

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Janus Henderson Group PLCPassive13G———
Adage Capital Management, L.P.Passive13G———
Squadron Master Fund LPPassive13G/A———
Spruce Street Capital LPPassive13G———
Millennium Management LLCPassive13G———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
———75955J402—